Conducting collaborative research locally, nationally and globally.
You are viewing an old version of this page. View the current version.
Compare with Current View Page History
« Previous Version 3 Next »
de Oliveira, C., Gatov, E., Rosella, L., Chen, S., Strauss, R., Azimaee, M., Paterno, E., Guttmann, A., Ministry of Children, Community Social Services & Ices Working Group 2022. Describing the linkage between administrative social assistance and health care databases in Ontario, Canada. Int J Popul Data Sci, 7(1):1689.
de Oliveira, C., Mondor, L., Wodchis, W.P. & Rosella, L.C. 2022. Looking beyond administrative health care data: The role of socioeconomic status in predicting future high-cost patients with mental health and addiction. Can J Psychiatry, 67(2):7067437211004882.
Dai, W.F., Beca, J.M., Nagamuthu, C., Liu, N., de Oliveira, C., Earle, C.C., Trudeau, M., Mercer, R.E. & Chan, K.K.W. 2022. Comparative effectiveness and safety of pertuzumab and trastuzumab plus chemotherapy vs trastuzumab plus chemotherapy for treatment of metastatic breast cancer. JAMA Netw Open, 5(2):e2145460.
Dai, W.F., de Oliveira, C., Blommaert, S., Pataky, R.E., Tran, D., Aurangzeb, Z., Kendell, C., Folkins, C., Somayaji, C., Dowden, J., Cheung, W., Strumpf, E., Beca, J.M., McClure, C., Urquhart, R., McDonald, J.T., Alvi, R., Turner, D., Peacock, S., Denburg, A., Mercer, R.E., Munoz, C., Parmar, A., Tadrous, M., Takhar, P., Chan, K.K.W. & On Behalf Of The CanREValue Collaboration 2022. Mapping Canadian data assets to generate real-world evidence: lessons learned from Canadian real-world evidence for value of cancer drugs (CanREValue) Collaboration's RWE Data Working Group. Curr Oncol, 29(3):2046-2063.